Raymond James & Associates increased its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 13.3% in the 3rd quarter, HoldingsChannel reports. The fund owned 53,611 shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback